(R)-1-(2,6-Dichloro-3-fluorophenyl)ethanol, 95.0%, 10g

5-Chloromethyl-3-(4-nitro-phenyl)-[1,2,4]oxadiazole, 97.0%, 1g

4-((1S,3aR,4R,6aR)-4-(3,4-Dimethoxyphenyl)tetrahydro-1H,3H-furo[3,4-c]furan-1-yl)-2-methoxyphenol, 98%, 25mg

[2',4'-BIS(1,1-DIMETHYLETHYL)-6'-METHOXY[1,1'-BIPHENYL]-2-YL]DICYCLOHEXYLPHOSPHINE, 95%, 1g

2-(Diphenylphosphanyl)benzenesulfonic acid, 97%, 5g

Picrylsulfonic Acid (ca. 1% in N,N-Dimethylformamide) [for Detection of Primary Amines]10mL

2-Methylnicotinic Acid>98.0%(GC)(T)1g

2-Methyl-5-oxocyclopent-1-en-1-yl propionate, 95.0%, 5g

(E)-3-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)vinyl)pyridine, 98%, 1g

METHYL BROMODIFLUOROACETATE, 95.0%, 100g

tert-Butyl 5-bromo-1,2,3,6-tetrahydropyridine-1-carboxylate, 95.0%, 5g

N-(4-Fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)cyclopentanamine, 95.0%, 1g

Gal alpha(1-3) N-Glycan 2AB (500pmol/vial)>95.0%(HPLC)1vial